<p>The aim of this study was to assess the causal relationship between habitual walking pace and cardiovascular disease risk using a Mendelian randomisation approach. We performed both one- and two-sample Mendelian randomisation analyses in a sample of 340,000 European ancestry participants from UK Biobank, applying a range of sensitivity analyses to assess pleiotropy and reverse causality. We used a latent variable framework throughout to model walking pace as a continuous exposure, despite being measured in discrete categories, which provided more robust and interpretable causal effect estimates. Using one-sample Mendelian randomisation, we estimated that a 1 mph (i.e., 1.6 kph) increase in self-reported habitual walking pace corresponds to a 63% (hazard ratio (HR) = 0.37, 95% confidence interval (CI), 0.25–0.55, P = 2.0 × 10–6) reduction in coronary artery disease risk. Using conditional analyses, we also estimated that the proportion of the total effect on coronary artery disease mediated through BMI was 45% (95% CI 16–70%). We further validated findings from UK Biobank using two-sample Mendelian randomisation with outcome data from the CARDIoGRAMplusC4D consortium. Our findings suggest that interventions that seek to encourage individuals to walk more briskly should lead to protective effects on cardiovascular disease risk.</p>
Funding
RESET: REmission of diabetes and improved diastolic function by combining Structured Exercise with meal replacemenT and food reintroduction.
Timmins, I.R., Zaccardi, F., Yates, T. et al. Mendelian randomisation and mediation analysis of self-reported walking pace and coronary artery disease. Sci Rep 14, 9995 (2024)
Analysis on UK Biobank data was performed under application number 33266, covered by the general ethical approval for UK Biobank studies from the National Health Service National Research Ethics. Because of the sensitive individual‐level nature of these data, they are not available to share by the authors but can be accessed by application directly to the UK Biobank. Publicly available genome‐wide association summary data from the CARDIoGRAMplusC4D consortium was used for validation analyses, and the details for accessing this data is available at the cited sources. Ethical approval and participant consent were obtained in each of the original studies that generated the data. Other datasets from this study are available from the corresponding author.